Yellowhair et al. showed that CXCL1/CXCR2 signaling contributes to newborn brain inflammation in an in-vitro model of preclinical chorioamnionitis and that blocking the CXCR2 receptor reduces neuroinflammation in different white matter regions (36). Here, CXCL1 is linked to inflammation.